Phase I Dose-Escalation Study of Onartuzumab as a Single Agent and in Combination with Bevacizumab in Patients with Advanced Solid Malignancies
暂无分享,去创建一个
P. Hegde | M. Ratain | R. Salgia | J. Bothos | B. Polite | R. Moss | I. Nijem | J. Mehnert | A. Peterson | Premal H. Patel | S. Eppler | D. Catenacci | S. Kaur | S. Bai | Wei Yu | Ihsan Nijem